Featured News Archive

Page 1 2 3 4 5 6 7 8 9 10 11 12 View All

May 26, 2021
News
Robbins Geller and Attorneys Receive Top Rankings by Chambers USA for the Twelfth Consecutive Year
May 26, 2021
News
Rite Aid Loses Bid to Force Arbitration of Generic Drug Price Fraud Claims in Ninth Circuit Victory Robbins Geller Obtained for Consumers
May 24, 2021
News
Robbins Geller Wins Class Certification for Endo Investors
May 21, 2021
News
Robbins Geller Prevails Over Motion to Dismiss in Under Armour Securities Class Action
May 12, 2021
News
The National Law Journal Recognizes Robbins Geller as 2021 Elite Trial Lawyers Finalist in Securities Litigation, Class Action, and Privacy/Data Breach Practice Areas
May 4, 2021
News
Robbins Geller Partners Aelish Baig and Jessica Shinnefield Recognized as “Born Leaders” and Plaintiffs’ Lawyers Trailblazers by The National Law Journal
April 30, 2021
News
Robbins Geller Secures Appellate Win After Supreme Court of New York Appellate Division Affirms Denial of Motion to Dismiss in Securities Class Action Against Alnylam Pharmaceuticals, Inc.
April 29, 2021
News
Robbins Geller Partner Mark Dearman Featured in Lawdragon’s Lawyer Limelight
April 22, 2021
News
Exelon Investors Beat Back Motions to Dismiss in Securities Class Action
April 21, 2021
News
Robbins Geller Defeats Motions to Dismiss in SPAC Securities Class Action
April 20, 2021
News
Eight Robbins Geller Attorneys Named as Top Lawyers by San Diego Magazine
April 19, 2021
Press Release
Robbins Geller Rudman & Dowd LLP Announces Former Assistant Attorney General Jonathan Zweig Has Joined the Firm’s Manhattan Office
April 12, 2021
Press Release
Robbins Geller Rudman & Dowd LLP Launches SPAC Task Force
April 1, 2021
News
Benchmark Litigation Recognizes Robbins Geller with San Diego Firm of the Year and Impact Case Awards; Partner Debra Wyman Awarded San Diego Litigator of the Year and California Plaintiff Litigator of the Year
March 31, 2021
News
Robbins Geller Defeats Motion to Dismiss in Super Micro Computer Securities Class Action
March 30, 2021
News
Valeant Investors Achieve Record $1.21 Billion Recovery
March 24, 2021
News
ISS SCAS Top 50 Report Ranks Robbins Geller First for Recovering $1.6 Billion for Investors in 2020, More than Any Other Plaintiffs Firm
March 15, 2021
News
Investors Prevail Against Defendants’ Motion to Dismiss in Altria Securities Class Action
March 12, 2021
News
Robbins Geller Achieves $30 Million Settlement for ADT Investors in Securities Class Action
March 10, 2021
News
Robbins Geller Defeats Motion to Dismiss in Vanda Pharmaceuticals Securities Class Action
February 26, 2021
News
“Landmark” $650 Million Settlement in Facebook Biometric Class Action Approved as a “Major Win” for Consumers in the Area of Digital Privacy
February 17, 2021
News
Robbins Geller’s Desiree Cummings Appointed to Plaintiffs’ Steering Committee in Blackbaud Data Breach MDL
February 17, 2021
News
Robbins Geller Defeats Motion to Dismiss in COVID-19 Vaccine Securities Class Action
February 8, 2021
News
Robbins Geller Recovers $87.5 Million for Southern Company Investors
February 5, 2021
News
Litigators of the Week: How Robbins Geller Landed a $1.2B Settlement in the Valeant Pharmaceuticals Securities Case
February 1, 2021
News
Partner Nathan Bear Appointed to Market Advisory Council by the CII for Second Consecutive Year
January 28, 2021
Awards & Recognition
Eleven Robbins Geller Partners Named Leading Lawyers in America by Lawdragon
January 21, 2021
News
Robbins Geller Prevails Over Motion to Dismiss in Anadarko Petroleum Securities Class Action
January 20, 2021
News
Robbins Geller Defeats Motion to Dismiss in Acadia Healthcare Securities Class Action
December 30, 2020
News
Robbins Geller Defeats Motions to Dismiss in Nissan Securities Class Action

View Current Featured News Items

Main Menu